| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |